Targeted temperature management (TTM) has been proposed to reduce mortality and improve neurological outcomes in postcardiac arrest and other critically ill patients. TTM implementation may vary considerably among hospitals, and “high-quality TTM” definitions are inconsistent. This systematic literature review in relevant critical care conditions evaluated the approaches to and definitions of TTM quality with respect to fever prevention and the maintenance of precise temperature control. Current evidence on the quality of fever management associated with TTM in cardiac arrest, traumatic brain injury, stroke, sepsis, and critical care more generally was examined. Searches were conducted in Embase and PubMed (2016 to 2021) following PRISMA guidelines. In total, 37 studies were identified and included, with 35 focusing on postarrest care. Frequently-reported TTM quality outcomes included the number of patients with rebound hyperthermia, deviation from target temperature, post-TTM body temperatures, and number of patients achieving target temperature. Surface and intravascular cooling were used in 13 studies, while one study used surface and extracorporeal cooling and one study used surface cooling and antipyretics. Surface and intravascular methods had comparable rates of achieving target temperature and maintaining temperature. A single study showed that patients with surface cooling had a lower incidence of rebound hyperthermia. This systematic literature review largely identified cardiac arrest literature demonstrating fever prevention with multiple TTM approaches. There was substantial heterogeneity in the definitions and delivery of quality TTM. Further research is required to define quality TTM across multiple elements, including achieving target temperature, maintaining target temperature, and preventing rebound hyperthermia.
Get full access to this article
View all access options for this article.
References
1.
AlnabelsiTS, FaulknerSP, CookM, et al.Passive antipyretic therapy is not as effective as invasive hypothermia for maintaining normothermia after cardiac arrest. Am J Emerg Med, 2021; 50:202–206.
2.
ArvidssonL, LindgrenS, MartinellL, et al.Target temperature 34 vs. 36°C after out-of-hospital cardiac arrest - a retrospective observational study. Acta Anaesthesiol Scand, 2017; 61:1176–1183.
3.
BeckerL, BergRA, CallawayCW, et al.R3 Report | Requirement, Rationale, Reference. Resuscitation Standards for Hospitals. The Joint Commission: Oakbrook Terrace, IL; 2021; pp. 1–7.
4.
BehringerW. Targeted temperature management: A health economic perspective. BMC Emerg Med, 2015; 15:A5.
5.
BernalW, MurphyN, BrownS, et al.A multicentre randomized controlled trial of moderate hypothermia to prevent intracranial hypertension in acute liver failure. J Hepatol, 2016; 65:273–279.
6.
BrayJE, StubD, BloomJE, et al.Changing target temperature from 33°C to 36°C in the ICU management of out-of-hospital cardiac arrest: A before and after study. Resuscitation, 2017; 113:39–43.
7.
Bro-JeppesenJ, KjaergaardJ, WanscherM, et al.Systemic inflammatory response and potential prognostic implications after out-of-hospital cardiac arrest: A substudy of the target temperature management trial. Crit Care Med, 2015; 43:1223–1232.
8.
CasamentoA, MinsonA, RadfordS, et al.A comparison of therapeutic hypothermia and strict therapeutic normothermia after cardiac arrest. Resuscitation, 2016; 106:83–88.
9.
ChangHC, TsaiMS, KuoLK, et al.Factors affecting outcomes in patients with cardiac arrest who receive target temperature management: The multi-center TIMECARD registry. J Formos Med Assoc, 2022; 121(1 Pt 2):294–303.
10.
ChienYS, TsaiMS, HuangCH, et al.Outcomes of Targeted Temperature Management for In-Hospital and Out-Of-Hospital Cardiac Arrest: A Matched Case-Control Study Using the National Database of Taiwan Network of Targeted Temperature Management for Cardiac Arrest (TIMECARD) Registry. Med Sci Monit, 2021; 27:e931203.
11.
CallawayCW, CopplerPJ, FaroJ, et al.Association of initial illness severity and outcomes after cardiac arrest with targeted temperature management at 36°C or 33°C. JAMA Netw Open, 2020; 3:e208215.
12.
CirciumaruB, BaldockG, CohenJ. A prospective study of fever in the intensive care unit. Intensive Care Med, 1999; 25:668–673.
13.
CordozaM, ThompsonH, BridgesE, et al.Association Between Target Temperature Variability and Neurologic Outcomes for Patients Receiving Targeted Temperature Management at 36°C After Cardiac Arrest: A Retrospective Cohort Study. Ther Hypothermia Temp Manag, 2021; 11:103–109.
14.
DankiewiczJ, CronbergT, LiljaG, et al.Hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med, 2021; 384:2283–2294.
15.
De FazioC, SkrifvarsMB, SøreideE, et al.Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest: An analysis of the TTH48 trial. Crit Care, 2019; 23:61.
16.
De FazioC, SkrifvarsMB, SøreideE, et al.Quality of targeted temperature management and outcome of out-of-hospital cardiac arrest patients: A post hoc analysis of the TTH48 study. Resuscitation, 2021; 165:85–92.
17.
DüggelinR, MaggioriniM, VoigtsbergerS, et al.Increased protocol adherence and safety during controlled normothermia as compared to hypothermia after cardiac arrest. J Crit Care, 2021; 63:146–153.
18.
EndNote [computer program]. Version EndNote X9. Philadelphia, PA, 2013.
19.
FoudraineNA, AlgargoushA, van OschFH, et al.A multimodal sevoflurane-based sedation regimen in combination with targeted temperature management in post-cardiac arrest patients reduces the incidence of delirium: An observational propensity score-matched study. Resuscitation, 2021; 159:158–164.
20.
GajarskiRJ, SmitkoK, DespresR, et al.Cost-effectiveness analysis of alternative cooling strategies following cardiac arrest. SpringerPlus, 2015; 4:427.
21.
GloverGW, ThomasRM, VamvakasG, et al.Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest-an analysis of the TTM trial data. Crit Care, 2016; 20(1):381.
22.
GoreckaM, HanleyA, BurkeF, et al.Targeted temperature management in cardiovascular disease complicated by cardiac arrest. Ir J Med Sci, 2017; 186:123–127.
23.
GrandJ, HassagerC, Bro-JeppesenJ, et al.Impact of hypothermia on oxygenation variables and metabolism in survivors of out-of-hospital cardiac arrest undergoing targeted temperature management at 33°C versus 36°C. Ther Hypothermia Temp Manag, 2021; 11(3):170–178.
24.
GrossestreuerAV, GaieskiDF, DonninoMW, et al.Magnitude of temperature elevation is associated with neurologic and survival outcomes in resuscitated cardiac arrest patients with postrewarming pyrexia. J Crit Care, 2017; 38:78–83.
25.
HeardK, PeberdyMA, SayreMR, et al.A randomized controlled trial comparing the Arctic Sun to standard cooling for induction of hypothermia after cardiac arrest. Resuscitation, 2010; 81(1):9–14.
26.
HolmA, KirkegaardH, TacconeF, et al.Cold fluids for induction of targeted temperature management: A sub-study of the TTH48 trial. Resuscitation, 2020; 148:90–97.
27.
HovdenesJ, RoyslandK, NielsenN, et al.A low body temperature on arrival at hospital following out-of-hospital-cardiac-arrest is associated with increased mortality in the TTM-study. Resuscitation, 2016; 107:102–106.
28.
JavanbakhtM, MashayekhiA, HemamiMR, et al.Cost-effectiveness analysis of intravascular targeted temperature management after cardiac arrest in England. PharmacoEconomics Open, 2022; 6:549–562.
29.
KheraR, HumbertA, LerouxB, et al.Hospital variation in the utilization and implementation of targeted temperature management in out-of-hospital cardiac arrest. Circ Cardiovasc Qual Outcomes, 2018; 11(11):e004829.
30.
KimYS, ChoYH, SungK, et al.Target temperature management may not improve clinical outcomes of extracorporeal cardiopulmonary resuscitation. J Intensive Care Med, 2018; 34(10):790–796
31.
KimSH, YounCS, KimH.J, et al. Prognostic value of serum albumin at admission for neurologic outcome with targeted temperature management after cardiac arrest. Emerg Med Int, 2019; 2019:6132542.
32.
KimSH, ParkKN, YounCS, et al.Outcome and status of postcardiac arrest care in Korea: Results from the Korean Hypothermia Network Prospective Registry. Clin Exp Emerg Med, 2020; 7(4):250–258.
33.
KimK, LeeBK, ParkJS, et al.Impact of controlled NORMOTHERMIA following hypothermic targeted temperature management for post-rewarming fever and outcomes in post-cardiac arrest patients: A propensity score-matched analysis from a multicentre registry. Resuscitation, 2021; 162:284–291.
34.
KirkegaardH, SøreideE, de HaasI, et al.Targeted temperature management for 48 vs. 24 hours and neurologic outcome after out-of-hospital cardiac arrest: A Randomized Clinical Trial. JAMA, 2017; 318:341–350.
35.
KleissnerM, SramkoM, KatuznerJ, et al.Mid-term clinical outcomes of out-of-hospital cardiac arrest patients treated with targeted temperature management at 34–36°C versus 32–34°C. Heart Lung, 2019; 48(4):273–277.
36.
LascarrouJ, DumasF, BougouiriW, et al.Temporal trends in the use of targeted temperature management after cardiac arrest and association with outcome: Insights from the Paris Sudden Death Expertise Centre. Critic Care, 2019; 23:391–401.
37.
LeeHY, LeeBK, LeeDH, et al.Turn-to-shockable rhythm has comparable neurologic outcomes to initial shockable rhythm in out-of-hospital cardiac arrest patients who underwent targeted temperature management. Ther Hypothermia Temp Manag, 2020; 10(4):220–228.
38.
LookX, LiH, NgM, et al.Randomized controlled trial of internal and external targeted temperature management methods in post- cardiac arrest patients. Am J Emerg Med, 2018; 36:66–72.
39.
MaekawaT, KanedaK, TsurutaR, et al.Precision and Safety of an Intravascular Temperature Management System for Postcardiac Arrest Syndrome Patients: A Multicenter Clinical Trial (COOL-ARREST JP). Ther Hypothermia Temp Manag, 2020; 10:179–185.
40.
MakkerP, ShimadaYJ, MisraD, et al.Clinical effect of rebound hyperthermia after cooling postcardiac arrest: A Retrospective Cohort Study. Ther Hypothermia Temp Manag, 2017; 7:137–140.
41.
MarkotaA, FluherJ, KitB, et al.The introduction of an esophageal heat transfer device into a therapeutic hypothermia protocol: A prospective evaluation. Am J Emerg Med, 2016; 34:741–745.
42.
MerchantRM, BeckerLB, AbellaBS, et al.Cost-effectiveness of therapeutic hypothermia after cardiac arrest. Circ Cardiovasc Qual Outcomes, 2009; 2:421–428.
43.
NayeriA, BhatiaN, HolmesB, et al.Temperature variability during targeted temperature management is not associated with neurological outcomes following cardiac arrest. Am J Emerg Med, 2017; 35:889–892.
44.
NielsenN, WetterslevJ, CronbergT, et al.Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med, 2013; 369:2197–2206.
45.
NishikimiM, OguraT, NishidaK, et al.Outcome related to level of targeted temperature management in postcardiac arrest syndrome of low, moderate, and high severities: A nationwide multicenter prospective registry. Crit Care Med, 2021; 49:e741–e750.
46.
NolanJP, SoarJ, CariouA, et al.European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-resuscitation Care 2015: Section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015. Resuscitation, 2015; 95:202–222.
47.
NutmaS, Tjepkema-CloostermansMC, RuijterBJ, et al.Effects of targeted temperature management at 33°C vs. 36°C on comatose patients after cardiac arrest stratified by the severity of encephalopathy. Resuscitation, 2022; 173:147–153.
48.
PageMJ, McKenzieJE, BossuytPM, et al.The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med, 2021; 18:e1003583.
49.
PanchalAR, BartosJA, CabañasJG, et al.Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation, 2020; 142:S366–S468.
50.
PeberdyMA, CallawayCW, NeumarRW, et al.Part 9: Post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation, 2010; 122:S768–S786.
51.
PowersWJ, RabinsteinAA, AckersonT, et al.Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2019; 50:e344–e418.
52.
RahmigJ, KuhnM, NeugebauerH, et al.Normothermia after decompressive surgery for sapcey occupying middle cerebral artery infarction: A protocol-based approach. BMC Neurol, 2017; 17:205.
53.
RosmanJ, HentzienM, DrameM, et al.A comparison between intravascular and traditional cooling for inducing and maintaining temperature control in patients following cardiac arrest. Anaesth Crit Care Pain Med, 2018; 37(2):129–134.
54.
SakuraiA, IharaS, TagamiR, et al.Parameters influencing brain oxygen measurement by regional oxygen saturation in postcardiac arrest patients with targeted temperature management. Ther Hypothermia Temp Manag, 2020; 10(1):71–75.
55.
SawyerKN, MooneyM, NorrisG, et al.COOL-ARREST: Results from a pilot multicenter, prospective, single-arm observational trial to assess intravascular temperature management in the treatment of cardiac arrest. Ther Hypothermia Temp Manag, 2019; 9(1):56–62.
56.
SungG, BossonN, KajiAH, et al.Therapeutic hypothermia after resuscitation from a non-shockable rhythm improves outcomes in a regionalized system of cardiac arrest care. Neurocrit Care, 2016; 24:90–96.
57.
TacconeFS, PicettiE, VincentJL. High quality targeted temperature management (TTM) after cardiac arrest. Crit Care, 2020; 24:6.
58.
ThompsonHJ. Evidence-base for Fever interventions following stroke. Stroke, 2015; 46:e98–e100.
59.
VattanavanitV, BhurayanontachaiR. Clinical outcomes of 3-year experience of targeted temperature management in patients with out-of-hospital cardiac arrest at Songklanagarind Hospital in Southern Thailand: An analysis of the MICU-TTM registry. Open Access Emerg Med, 2016; 8:67–72.
60.
VattanavanitV, UppanisakornS, NilmojeT. Post out-of-hospital cardiac arrest care in a tertiary care center in southern Thailand: From emergency department to intensive care. Hong Kong J Emerg Med, 2020; 27(3):155–161.
61.
Veritas Health Innovation M, Australia. Covidence Systematic Review Software; 2023. Available from: www.covidence.org [Last accessed: May16, 2023].
62.
WalterEJ, Hanna-JummaS, CarrarettoM, et al.The pathophysiological basis and consequences of fever. Crit Care, 2016; 20:200.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
